Pluriomics is a biotech company with R&D laboratories in Leiden (the Netherlands) and production facilities in Gosselies (Belgium). The company is focused on the development of fully functional human assay systems for use in drug discovery and development. Based on our novel proprietary methods for differentiation of stem cells we develop highly functional cell types like our Pluricyte Cardiomyocytes. We use these cells in combination with phenotypic assays to deliver high quality results.
Company Details
- Employees
- 1
- Founded
- 2010
- Address
- Gallileiweg 8, Leiden,zuid-Holland 2333bd,netherlands
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- pluriomics.com
- Keywords
- cardiomyocytes, iPSC cells, drug discovery, cell based assays, safety pharmacology, drug development.
- HQ
- Leiden, Zuid-Holland
Pluriomics Questions
Pluriomics's website is pluriomics.com
Pluriomics's LinkedIn profile is https://nl.linkedin.com/company/pluriomics
Pluriomics has
1 employees.
View email and phone details for 1
employees at Pluriomics.
Pluriomics's industry is
Biotechnology Research
Pluriomics's top competitors are
Voorieder1.nl,
Ncardia,
Invenis Biotherapies,
Salto Therapeutics,
Syndivia,
Massachusetts General Hospital,
Anagenesis Biotechnologies,
Jalon Therapeutics,
Cellistic,
Ofichem Group.
Pluriomics's categories are Biotechnology Research
Pluriomics's founding year is 2010
